Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...

Correspondence to Dr Adam Ivan Semciw, Department of Rehabilitation, Nutrition and Sport, Latrobe University, Bundoora, VIC 3086, Australia; a.semciw{at}latrobe.edu.au Objectives To determine, in ...

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...